Cerus gains as Craig Hallum launches at Buy on return to growth [Seeking Alpha]
Cerus Corporation (CERS)
Last cerus corporation earnings: 2/20 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cerus.com/investors/investor-overview/default.aspx
Company Research
Source: Seeking Alpha
Analyst Bill Bonello pointed out that after five consecutive years of growth exceeding 20%, Cerus' ( CERS ) product revenue fell ~4% in 2023. “We view the 2023 decline as an anomaly since many U.S. blood centers reduced INTERCEPT kit inventories relative to prior periods,” Bonello wrote, referring to the company's main revenue generator. “We believe that blood center inventories have stabilized, which should lead to a rebound in kit growth,” the analyst added as he argued that underlying demand for INTERCEPT remained intact and only supply chain issues had led to a decline in investors. According to Bill, the stock has lost more than 50% since 2022-end amid revised estimates and multiple contractions, trading at 2x in terms of 2025 product revenue with a sharp discount to the historical average of more than x5. Craig Hallum projects CERS' product revenue to grow ~11% in 2024 and 2025, and issues a 12-month price target of $5 on the stock, indicating an EV multiple of 5x on it
Show less
Read more
Impact Snapshot
Event Time:
CERS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERS alerts
High impacting Cerus Corporation news events
Weekly update
A roundup of the hottest topics
CERS
News
- Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024Business Wire
- Cerus Corporation (NASDAQ:CERS) is a favorite amongst institutional investors who own 64% [Yahoo! Finance]Yahoo! Finance
- Cerus Co. (NASDAQ: CERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $5.00 price target on the stock.MarketBeat
- Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life [Yahoo! Finance]Yahoo! Finance
- Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeBusiness Wire
CERS
Earnings
- 3/5/24 - In-Line
CERS
Sec Filings
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- 4/26/24 - Form ARS
- CERS's page on the SEC website